Contextualizing these findings to demyelinating lesion tissue of MS patients, in which we found increased microglial EP2 expression in the lesion and higher TMEM119 intensity in EP2+ cells, the enhanced EP2 signaling could be a response mechanism to counteract demyelination and induce a potential resolving microglial phenotype. The gene discussed is TMEM119; the disease is myeloid sarcoma.